Author

Gaurav Raj Dwivedi

Observed names: Dwivedi, Gaurav R., Dwivedi, Gaurav Raj, Gaurav Dwivedi, Gaurav R Dwivedi, Gaurav R. Dwivedi

Institutions: Baba Raghav Das Medical College, Regional Medical Research Centre, Indian Council of Medical Research, Regional Medical Research Centre, Regional Medical Research Centre, Academy of Scientific and Innovative Research

Observed institutions: Georgia Institute of Technology, Babasaheb Bhimrao Ambedkar University, Emory University, Baba Raghav Das Medical College, Regional Medical Research Centre, The Wallace H. Coulter Department of Biomedical Engineering, Regional Medical Research Center, Indian Council of Medical Research, Regional Medical Research Centre, Regional Medical Research Centre, Council of Scientific and Industrial Research, Central Institute of Medicinal and Aromatic Plants, Academy of Scientific and Innovative Research

ORCID: 0000-0003-4704-7116

Observed ORCID: 0000-0003-4704-7116

OpenAlex ID: A5074623171

Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review

2022 · Ankita Parmanik, Soumyajit Das, et al. · Current Microbiology · 302

PDF

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020

2020 · Manoj V. Murhekar, Tarun Bhatnagar, et al. · The Indian Journal of Medical Research · 196

PDF

SARS-CoV-2 Antibody Prevalence in India: Findings from the Second Nationwide Household Serosurvey, August - September 2020

2020 · Manoj V Murhekar, Tarun Bhatnagar, et al. · The Lancet Global Health · 191

PDF

SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021

2021 · Manoj V. Murhekar, Tarun Bhatnagar, et al. · International Journal of Infectious Diseases · 148

PDF

Potential of rosemary oil to be used in drug-resistant infections.

2007 · Suaib Luqman, Gaurav R Dwivedi, et al. · PubMed · 90

Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid‐Resistant E scherichia coli

2013 · Anupam Maurya, Gaurav R. Dwivedi, et al. · Chemical Biology & Drug Design · 78

Next-Generation Diagnostic with CRISPR/Cas: Beyond Nucleic Acid Detection

2022 · Pooja Bhardwaj, Rajni Kant, et al. · International Journal of Molecular Sciences · 74

PDF

Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid‐ and Multidrug‐resistant Escherichia coli

2014 · Gaurav Raj Dwivedi, Anupam Maurya, et al. · Chemical Biology & Drug Design · 73

Synergy of clavine alkaloid ‘chanoclavine’ with tetracycline against multi-drug-resistant E. coli

2018 · Gaurav Raj Dwivedi, Anupam Maurya, et al. · Journal of Biomolecular Structure and Dynamics · 72

Prevalence and factors associated with tuberculosis infection in India

2023 · Sriram Selvaraju, Banurekha Velayutham, et al. · Journal of Infection and Public Health · 63

4‐Hydroxy‐α‐Tetralone and its Derivative as Drug Resistance Reversal Agents in Multi Drug Resistant E scherichia coli

2013 · Gaurav R. Dwivedi, Harish C. Upadhyay, et al. · Chemical Biology & Drug Design · 63

Antibiotics potentiating potential of catharanthine against superbug Pseudomonas aeruginosa

2017 · Gaurav Raj Dwivedi, Rekha Tyagi, et al. · Journal of Biomolecular Structure and Dynamics · 57

Antimicrobial activity of Eucalyptus citriodora essential oil

2008 · Suaib Luqman, Gaurav Raj Dwivedi, et al. · 49

Phytol Derivatives as Drug Resistance Reversal Agents

2014 · Harish C. Upadhyay, Gaurav R. Dwivedi, et al. · ChemMedChem · 44

PDF

Synergy Potential of Indole Alkaloids and Its Derivative against Drug‐resistant Escherichia coli

2015 · Gaurav Raj Dwivedi, Shikha Gupta, et al. · Chemical Biology & Drug Design · 41

Bioenhancing and Antimycobacterial Agents fromAmmannia multiflora

2011 · Harish Upadhyay, Gaurav Dwivedi, et al. · Planta Medica · 39

Synthesis of diverse analogues of Oenostacin and their antibacterial activities

2006 · Vandana Srivastava, Mahendra P. Darokar, et al. · Bioorganic & Medicinal Chemistry · 38

Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli

2015 · Gaurav Raj Dwivedi, Nimisha Tiwari, et al. · Applied Microbiology and Biotechnology · 37

Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin

2021 · Rajni Kant, Gaurav Dwivedi, et al. · Journal of Travel Medicine · 27

PDF

Antimycobacterial activity of fractions and isolated compounds from Vetiveria zizanioides

2011 · Shikha Gupta, Gaurav R. Dwivedi, et al. · Medicinal Chemistry Research · 27

Nano Particles: Emerging Warheads Against Bacterial Superbugs

2016 · Gaurav Raj Dwivedi, . Sanchita, et al. · Current Topics in Medicinal Chemistry · 24

Hospital-Based Surveillance of Respiratory Viruses Among Children Under Five Years of Age with ARI and SARI in Eastern UP, India

2024 · Hirawati Deval, Mitali Srivastava, et al. · Viruses · 22

PDF

Tricyclic Sesquiterpenes From V etiveria zizanoides ( L .) Nash as Antimycobacterial Agents

2013 · Gaurav R. Dwivedi, Shikha Gupta, et al. · Chemical Biology & Drug Design · 21

Drug resistance reversal potential of multifunctional thieno[3,2-c]pyran via potentiation of antibiotics in MDR P. aeruginosa

2021 · Gaurav Raj Dwivedi, Reeta Rai, et al. · Biomedicine & Pharmacotherapy · 20

PDF

Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India

2022 · Kamran Zaman, Anita M. Shete, et al. · Frontiers in Medicine · 18

Works count: 91

Citation count: 2,083

H-index: 22

I10-index: 35